Blog
920 Articles
Using Humor to Face Pancreatic Cancer
Richard Liles has a stage IV pancreatic cancer diagnosis but feels it is very important to keep a sense of humor throughout.
I’m a Person, Not a Diagnosis
Burt Rosen discusses his life with PNET, making sure he is a person, and more than his diagnosis.
Research Updates from ASCO GI 2023
Read the latest clinical trial and research updates from the 2023 ASCO GI meeting, including a review of genetic testing uptake.
Learning All I Can About PNET
Burt Rosen received a double whammy diagnosis of PNET and kidney cancer, but he’s determined to learn as much as he can about his disease.
Targeting the Oxidation Pathway to Treat Advanced Pancreatic Cancer
Researchers are testing a new drug that targets the oxidation pathway in order to make standard chemotherapy more effective for stage IV pancreatic cancer.
You Can Do Anything
Long-term survivor Jay Bozick carries the BRCA2 mutation, which has made newer treatments an option for his pancreatic cancer.
Meet the Researcher: Hiroyuki Kato, M.D., Ph.D.
Researcher Dr. Hiroyuki Kato has traveled from Japan to Boston for his research on IPMNs and pancreatic cancer.
Taking Chances to Beat Pancreatic Cancer
With a family history of pancreatic cancer, Jay Bozick discovered he carries the BRCA2 mutation, which directed his treatment.
Treatments and Clinical Trials
Let’s Win and the National Alliance for Hispanic Health’s Nuestras Voces program cosponsored a webinar about treatments and clinical trials.
Screening Programs Save High-Risk People
Dr. Michael Goggins explains who should undergo regular pancreatic cancer screening and where programs can be found.
A Year in Review: 2022 in Research
What progress was made in pancreatic treatment and screening? Learn about the major pancreatic cancer developments of 2022.
It Started With Acid Reflux
James Arnott thought he had an acid stomach but a scan showed pancreatic cancer, and he soon had a Whipple procedure.
Testing a New Immunotherapy Combo in Advanced Pancreatic Cancer
Researchers are testing an approved immunotherapy drug with a new drug that works on T cells to make it more effective for pancreatic cancer.
NAPOLI-3 Trial Meets Primary Endpoint in Metastatic Disease
Dr. Tanios Bekaii-Saab explains the early positive results from the NAPOLI-3 clinical trial, testing the NALIRIFOX combination.
Let’s Win Pancreatic Cancer Survivors Series—Year Six
Join Let’s Win’s long-term survivors as they share their uplifting stories of treatment, resilience, and life after pancreatic cancer.